Lung volume reduction surgery for the treatment of chronic obstructive pulmonary disease.
Doyle
R L
RL
Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, California, USA.
Mark
J B
JB
D000768:Anesthesia, General; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004417:Dyspnea / Q000601:surgery; D017079:Exercise Tolerance; D005541:Forced Expiratory Volume / Q000502:physiology; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D017048:Health Care Costs; D006801:Humans; D008168:Lung / Q000503:physiopathology / Q000601:surgery; D008173:Lung Diseases, Obstructive / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D016040:Lung Transplantation; D018579:Patient Selection; D011013:Pneumonectomy / Q000009:adverse effects / Q000191:economics / Q000379:methods; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D011656:Pulmonary Emphysema / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery; D011788:Quality of Life; D011859:Radiography; D015656:Respiratory Mechanics / Q000502:physiology; D015996:Survival Rate
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011241:Prednisone